authors
- Wells, JC
- Sidhu, A
- Ding, K
- Heng, DYC
- Shepherd, F
- Ellis, Peter
- Bradbury, PA
- Jonker, DJ
- Moore, M
- Siu, LL
- Gelmon, KA
- Karapetis, C
- Shapiro, J
- Nott, L
- O’Callaghan, CJ
- Parulekar, WR
- Seymour, LK
- Smoragiewicz, M
- Monzon, JG
Complementary medicine (CM) use in phase III clinical trials (P3T) conducted by the Canadian Cancer Trials Group (CCTG)
Journal Articles
- Overview
- Research
- Identity
- Additional Document Info
- View All
Overview
status
publication date
- October 2019
has subject area
- 1112 Oncology and Carcinogenesis (FoR)
- Oncology & Carcinogenesis (Science Metrix)
published in
- Annals of Oncology Journal